Darren Dasburg | CEO, Clarus Biologics – Advancing Vaccine and Immunology Innovation with Novel Adjuvant Platforms

from Executive Insights for Life Sciences Innovators · host GeneCoda® Executive Search

In this episode of Executive Insights for Life Sciences Innovators, we sit down with Darren Dasburg, CEO of Clarus Biologics, a company advancing vaccine and immunology innovation through a novel adjuvant platform designed to improve immune responses, particularly in vulnerable populations. Darren shares insights on Clarus Biologics’ technology, its potential applications in global health, and the company’s strategy for bringing novel adjuvant solutions to market.Learn more at genecoda.com.Originally recorded and streamed on YouTube Live on May 19, 2025.

Episode metadata supplied by the publisher feed · Published Sep 8, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Darren Dasburg | CEO, Clarus Biologics – Advancing Vaccine and Immunology Innovation with Novel Adjuvant Platforms

0:00 34:37

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Executive Insights for Life Sciences Innovators?

This episode is 34 minutes long.

When was this Executive Insights for Life Sciences Innovators episode published?

This episode was published on September 8, 2025.

Can I download this Executive Insights for Life Sciences Innovators episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!